Phase II Study With Hiltonol and Dendritic Cells in Solid Tumors
Phase of Trial: Phase II
Latest Information Update: 14 Jun 2017
At a glance
- Drugs Dendritic cells (Primary) ; Poly ICLC (Primary)
- Indications Solid tumours
- Focus Therapeutic Use
- 10 Apr 2017 Status changed from recruiting to completed.
- 02 Dec 2015 Number of treatment arms changed from 1 to 2, A new cohort will explore the role of radiation therapy, looking for an abscopal effect as reported by ClinicalTrials.gov.
- 26 Jan 2015 Planned End Date changed from 1 Dec 2014 to 1 Dec 2016, as reported by ClinicalTrials.gov.